Histogen Inc. Common Stock
HSTO
HSTO was delisted on the 4th of October, 2023.
32 hedge funds and large institutions have $10.7M invested in Histogen Inc. Common Stock in 2016 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 16 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 4
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
26% less funds holding
Funds holding: 43 → 32 (-11)
30% less call options, than puts
Call options by funds: $83K | Put options by funds: $118K
36% less capital invested
Capital invested by funds: $16.8M → $10.7M (-$6.11M)
69% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 16
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$156K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$155K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
+$67.2K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$57.6K |
| 5 |
HM
HealthCor Management
New York
|
+$36.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$946K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$568K |
| 3 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$299K |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$254K |
| 5 |
ARTA
A.R.T. Advisors
New York
|
-$253K |
HSTO Hedge Fund Activity: Q1 2016 in Review
32 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in Histogen Inc. Common Stock (HSTO) for Q1 2016, worth a combined $10.7M — down 36% from $16.8M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of HSTO and 5 opened new positions — a net loss of 11 holders — while 4 trimmed existing stakes and 8 added.
The largest buyer was Jacobs Levy Equity Management, opening a new position worth an estimated $156K. The largest seller was Point72 Asset Management, exiting entirely with an estimated $946K sold.
- 32 institutional investors held Histogen Inc. Common Stock (HSTO) as of Q1 2016, down from 43 in Q4 2015.
- Funds reported $10.7M of Histogen Inc. Common Stock stock for Q1 2016, down 36% quarter-over-quarter.
- 5 funds opened new Histogen Inc. Common Stock positions in Q1 2016 and 16 closed out, a net change of -11 holders.
- The largest Histogen Inc. Common Stock buyer in Q1 2016 was Jacobs Levy Equity Management, an estimated $156K added.
- The largest Histogen Inc. Common Stock seller in Q1 2016 was Point72 Asset Management, an estimated $946K sold.
Based on aggregated 13F filings for Q1 2016.